HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

T Van Gorp; I Cadron; E Despierre; A Daemen; K Leunen; F Amant; D Timmerman; B De Moor; I Vergote

首页> 外文期刊>British Journal of Cancer >HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

【24h】

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

机译：HE4和CA125作为卵巢癌的诊断测试：卵巢恶性肿瘤风险算法的前瞻性验证

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Recently, a Risk of Ovarian Malignancy Algorithm (ROMA) utilising human epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as presenting a high or low risk for epithelial ovarian cancer (EOC). We validated this algorithm in an independent prospective study.

机译：背景：最近，利用人类附睾分泌蛋白4（HE4）和CA125的卵巢恶性肿瘤风险算法（ROMA）成功地将患者归为呈现上皮性卵巢癌（EOC）的高风险或低风险。我们在一项独立的前瞻性研究中验证了该算法。

著录项

来源
《British Journal of Cancer 》 |2011年第5期| 共8页
作者
T Van Gorp; I Cadron; E Despierre; A Daemen; K Leunen; F Amant; D Timmerman; B De Moor; I Vergote;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm [J] . T Van Gorp, I Cadron, E Despierre, British Journal of Cancer . 2011 ,第5期

机译：HE4和CA125作为卵巢癌的诊断测试：卵巢恶性肿瘤风险算法的前瞻性验证
2. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass [J] . KarlsenM.A., SandhuN., H?gdallC., Gynecologic Oncology: An International Journal . 2012 ,第2期

机译：评估HE4，CA125，卵巢恶性算法（ROMA）的风险和恶性指数（RMI）的风险作为盆腔肿块患者上皮性卵巢癌的诊断工具
3. Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer A Meta-analysis [J] . Dayyani Farshid, Uhlig Steffen, Colson Bertrand, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2016 ,第9期

机译：针对CA125和HE4的卵巢恶性肿瘤风险诊断与卵巢癌相关性的Meta分析。
4. Detection of Ovarian Malignancy from Combination of CA125 in Blood and TVUS Using Machine Learning [C] . Laboni Akter, Nasrin Akhter International Conference on Trends in Computational and Cognitive Engineering . 2021

机译：使用机器学习检测血液和触控器中CA125组合的卵巢恶性肿瘤
5. Role of ovarian cancer antigen CA125/MUC16 in development and cancer. [D] . Cheon, Dong-Joo (Ellen). 2009

机译：卵巢癌抗原CA125 / MUC16在发育和癌症中的作用。
6. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm [O] . T Van Gorp, I Cadron, E Despierre, 2011

机译：HE4和CA125作为卵巢癌的诊断测试：卵巢恶性肿瘤风险算法的前瞻性验证
7. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm [O] . Van Gorp, T, Cadron, I, Despierre, E, 2011

机译：HE4和CA125作为卵巢癌的诊断测试：卵巢恶性肿瘤风险算法的前瞻性验证

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

摘要

著录项

相似文献

相关主题

期刊订阅